Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly C Lee

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
The Annals of Pharmacotherapy|January 24, 2013
Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychoticsLucas Hill, Kelly C Lee
Psychiatry Research|January 30, 2020
Association of appropriate lithium monitoring and clinical outcomes in an outpatient psychiatric settingElika Hefazi, Kelly C Lee
The Mental Health Clinician|June 30, 2018
<i>Ayahuasca</i>: An ancient sacrament for treatment of contemporary psychiatric illness?Benjamin J Malcolm, Kelly C Lee
The Mental Health Clinician|December 7, 2023
Antidepressant prescribing in transgender and nonbinary individuals diagnosed with gender dysphoria and mood or anxiety disordersCasey M Tiefenthaler, Kelly C Lee
Neuropsychiatric Disease and Treatment|March 21, 2009
Transdermal selegiline for the treatment of major depressive disorderKelly C Lee, Jack J Chen
Journal of Pharmacy Practice|June 15, 2013
Dose-related paresthesias with venlafaxineLouise J Angelo, Kelly C Lee
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|March 10, 2006
Nonparkinsonism movement disorders in the elderlyJack J Chen, Kelly C Lee
The Journal of Clinical Psychiatry|December 15, 2025
Obstetric Outcomes With Second-Generation Long-Acting Injectable Versus Oral AntipsychoticsFarah Khorassani, Gemma Espejo, Kelly C Lee
Pharmacotherapy|March 26, 2004
Apraxia of lid opening: dose-dependent response to carbidopa-levodopaKelly C Lee, Ron Finley, Bruce Miller
Pharmaceuticals (Basel, Switzerland)|July 17, 2020
Safety of Repeated Administration of Parenteral Ketamine for DepressionDavid Feifel, David Dadiomov, Kelly C Lee
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
The Annals of Pharmacotherapy|January 24, 2013
Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychoticsLucas Hill, Kelly C Lee
Psychiatry Research|January 30, 2020
Association of appropriate lithium monitoring and clinical outcomes in an outpatient psychiatric settingElika Hefazi, Kelly C Lee
The Mental Health Clinician|June 30, 2018
<i>Ayahuasca</i>: An ancient sacrament for treatment of contemporary psychiatric illness?Benjamin J Malcolm, Kelly C Lee
The Mental Health Clinician|December 7, 2023
Antidepressant prescribing in transgender and nonbinary individuals diagnosed with gender dysphoria and mood or anxiety disordersCasey M Tiefenthaler, Kelly C Lee
Neuropsychiatric Disease and Treatment|March 21, 2009
Transdermal selegiline for the treatment of major depressive disorderKelly C Lee, Jack J Chen
Journal of Pharmacy Practice|June 15, 2013
Dose-related paresthesias with venlafaxineLouise J Angelo, Kelly C Lee
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|March 10, 2006
Nonparkinsonism movement disorders in the elderlyJack J Chen, Kelly C Lee
The Journal of Clinical Psychiatry|December 15, 2025
Obstetric Outcomes With Second-Generation Long-Acting Injectable Versus Oral AntipsychoticsFarah Khorassani, Gemma Espejo, Kelly C Lee
Pharmacotherapy|March 26, 2004
Apraxia of lid opening: dose-dependent response to carbidopa-levodopaKelly C Lee, Ron Finley, Bruce Miller
Pharmaceuticals (Basel, Switzerland)|July 17, 2020
Safety of Repeated Administration of Parenteral Ketamine for DepressionDavid Feifel, David Dadiomov, Kelly C Lee
Pageof 11